B
Last Price
52 Week Range
€0.29 - €0.29
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | €27.24M |
EV | €26.59M |
Shares Outstanding | 93.92M |
Beta | 1.09 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2024E | - |
P/Revenue 2024E | - |
Revenue | -5.00% |
EPS | - |
Operating Cash Flow | -6.80% |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2024E | - |
Net Profit Margin 2024E | - |
ROE 2024E | - |
ROCE 2023 | - |
DPS 2024E | - |
Payout Ratio 2024E | - |
Div. Yield 2024E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
Biocartis Group NV
BCART
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Moody, Roger
Employees
500
Website
www.biocartisgroupnv.beIPO Date
2015-04-27
Headquarters
Generaal de Wittelaan 11 B, Mechelen, Antwerp, 2800, Belgium
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.